01.12.2006 | Clinical Trial
Quality of Life Analyses in a Clinical Trial of DPPE (tesmilifene) Plus Doxorubicin Versus Doxorubicin in Patients with Advanced or Metastatic Breast Cancer: NCIC CTG Trial MA.19
Erschienen in: Breast Cancer Research and Treatment | Ausgabe 3/2006
Einloggen, um Zugang zu erhalten